{"SPADE_UN_28056": {"Sequence Information": {"Peptide Name": "Indolicidin [R12K,R13K]", "Sequence": "ILPWKWPWWPWKK", "Sequence Length": 13, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P33046", "uniprotUrl": "http://www.uniprot.org/uniprot/P33046", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin.", "Pubmed ID": "11695650", "Reference": "J Pept Sci. 2001;7:552-564", "Author": "Staubitz P, Peschel A, Nieuwenhuizen WF, Otto M, Götz F, Jung G, Jack RW", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/11695650"}, {"Title": "Improving the Activity of Trp-Rich Antimicrobial Peptides by Arg/Lys Substitutions and Changing the Length of Cationic Residues.", "Pubmed ID": "29671805", "Reference": "Biomolecules. 2018;8:E19", "Author": "Arias M, Piga KB, Hyndman ME, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29671805"}, {"Title": "Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin.", "Pubmed ID": "32126228", "Reference": "Biochim Biophys Acta. 2020;1862:183228", "Author": "Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32126228"}], "Mass": 1851.24, "PI": 10.3, "Net Charge": 3, "Hydrophobicity": -0.98, "Frequent Amino Acids": "WKP", "Absent Amino Acids": "ACDEFGHMNOQRSTUVY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 11, "Positive Residues": 3, "Negative Residues": 0, "SPADE ID": "SPADE_UN_28056", "Similar Sequences": [{"SPADE_ID": "SPADE_N_09545", "Similarity": 1.0, "Sequence": "ILPWKWPWWPW"}, {"SPADE_ID": "SPADE_N_09546", "Similarity": 1.0, "Sequence": "ILPWKWPWWP"}, {"SPADE_ID": "SPADE_N_09547", "Similarity": 1.0, "Sequence": "ILPWKWPWW"}], "Hemolytic Activity": "Human erythrocytes:100% Hemolysis=31.3 µM,Human PBMC:IC50=26.4 µM", "Target Organism": "Micrococcus luteus ATCC 9341(MIC=0.4µM),Escherichia coli ATCC 25922(MIC=16µM),Jurkat T-cell leukemia(IC50=9.5µM)"}}}